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Abstract
Dengue is a potentially fatal acute febrile illness caused by four mosquito-transmitted dengue viruses (DENV-1–4). Although
dengue outbreaks regularly occur in many regions of the Pacific, little is known about dengue in the Republic of the
Marshall Islands (RMI). To better understand dengue in RMI, we investigated an explosive outbreak that began in October
2011. Suspected cases were reported to the Ministry of Health, serum specimens were tested with a dengue rapid
diagnostic test (RDT), and confirmatory testing was performed using RT-PCR and IgM ELISA. Laboratory-positive cases were
defined by detection of DENV nonstructural protein 1 by RDT, DENV nucleic acid by RT-PCR, or anti-DENV IgM antibody by
RDT or ELISA. Secondary infection was defined by detection of anti-DENV IgG antibody by ELISA in a laboratory-positive
acute specimen. During the four months of the outbreak, 1,603 suspected dengue cases (3% of the RMI population) were
reported. Of 867 (54%) laboratory-positive cases, 209 (24%) had dengue with warning signs, six (0.7%) had severe dengue,
and none died. Dengue incidence was highest in residents of Majuro and individuals aged 10–29 years, and ,95% of
dengue cases were experiencing secondary infection. Only DENV-4 was detected by RT-PCR, which phylogenetic analysis
demonstrated was most closely related to a virus previously identified in Southeast Asia. Cases of vertical DENV
transmission, and DENV/Salmonella Typhi and DENV/Mycobacterium leprae co-infection were identified. Entomological
surveys implicated water storage containers and discarded tires as the most important development sites for Aedes aegypti
and Ae. albopictus, respectively. Although this is the first documented dengue outbreak in RMI, the age groups of cases and
high prevalence of secondary infection demonstrate prior DENV circulation. Dengue surveillance should continue to be
strengthened in RMI and throughout the Pacific to identify and rapidly respond to future outbreaks.
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Introduction
Dengue is the most common mosquito-borne viral illness in the
world, and is endemic throughout the tropics and subtropics where
,96 million cases occurred in 2010 [1,2]. Infection with any of
four dengue viruses (DENV-1–4), which are transmitted by select
Aedes species mosquitoes, can result in dengue, an acute febrile
illness characterized by headache, body pain, retro-orbital pain,
rash and leukopenia [2]. Although most DENV infections are
asymptomatic or subclinical [3], ,5% of dengue patients develop
severe dengue (including dengue hemorrhagic fever [DHF] and
dengue shock syndrome [4]).
Recent dengue outbreaks have been reported in the Pacific
islands, including Fiji [5], Palau [6], Kiribati [7], the Federated
States of Micronesia (FSM) [8–10], the Solomon Islands [11], and
Hawaii [12,13], with rates of attack and infection up to 6% [10]
and 27% [6], respectively. Travel between the Pacific islands and
dengue-endemic countries throughout the region facilitates DENV
circulation, which may result in outbreaks [7]. In example of this,
after an apparent absence of circulation in the Pacific Islands for
many years, DENV-4 was detected in the region in 2008 and
caused several outbreaks soon after [7,14].
Dengue was apparently first detected in the Republic of the
Marshall Islands (RMI) during an outbreak in 1989 in which
DENV-1 was isolated from cases on Majuro, Kwajalein and Ebon
atolls (U.S. Centers for Disease Control and Prevention [CDC],
unpublished data). In 1990 and 2004, DENV-2 and -1,
respectively, were detected in serum specimens collected from
PLOS ONE | www.plosone.org 1 September 2014 | Volume 9 | Issue 9 | e108445
RMI residents reported to CDC as having dengue-like illness
(CDC, unpublished data). In 2010, Ae. aegypti and Ae. albopictus
were detected in RMI during mosquito surveys (Harry M. Savage,
personal communication). Although dengue activity was not above
baseline in the Western Pacific Region of the World Health
Organization (WHO) in 2011, country-specific rates were highest
in RMI [15].
To enable early detection of dengue and other outbreak-prone
diseases, in 2009 a surveillance system was initiated in RMI that
included implementation of dengue rapid diagnostic tests (RDTs)
[16]. In October 2011, several RDT-positive cases were reported
to the RMI Ministry of Health (MOH) from Majuro atoll.
Following a rapid increase in cases, the RMI government declared
a state of emergency due to the outbreak. CDC, WHO, and other
partners assisted in responding to the outbreak [17]. Response
activities included use of RDTs to identify dengue patients and
monitor epidemiologic trends; clinical training on dengue case
management according to established guidelines [2]; vector
surveillance to direct public clean-up campaigns and vector
control activities; and public health education regarding dengue




RMI is composed of 29 atolls and five islands with a total land
mass of 70 square miles (sq mi) spread across ,750,000 sq mi of
ocean (Figure S1). The 2011 population of RMI was 53,158 (759
individuals/sq mi), 70% of which resided on Majuro atoll or Ebeye
island (7,413 and 80,117 individuals/sq mi, respectively) [18].
Forty percent of the population was aged #14 years, and the sex
ratio was 102 males to 100 females.
Investigation design
Surveillance data were collected during the outbreak, summa-
rized weekly, and reported to WHO. After the outbreak had
ended, a retrospective analysis of surveillance data was performed
to: 1) describe the epidemiology of the 2011–2012 outbreak,
including disease severity; 2) estimate the proportion of secondary
DENV infections; 3) describe the molecular epidemiology of the
DENV(s) responsible for the outbreak; and 4) identify the water
containers producing vector mosquitoes.
Data sources
Suspected cases identified at Majuro and Ebeye Hospitals were
reported directly to MOH via the Dengue Surveillance Form
(DSF; Figure S2A), which was implemented for the outbreak. DSF
data were reported to MOH via short wave radio from all other
health facilities. Case-patients’ ultimate severity of illness were
captured with a second DSF (Figure S2B) that was completed
upon patient discharge or follow-up evaluation.
Diagnostic testing
Serum specimens were collected from all suspected dengue cases
upon presentation to Majuro and Ebeye Hospitals and tested by
RDT (Dengue Duo, Standard Diagnostics, Haryana, India).
Convalescent specimens were collected upon discharge or during
follow-up evaluation. For suspected dengue cases that presented to
other health facilities in RMI, whole blood was collected at
presentation and tested by RDT at the health facility. A
convenience sample of both RDT-positive and-negative serum
specimens were sent to CDC for confirmatory testing by multiplex,
DENV-type-specific, real-time reverse transcriptase-polymerase
chain reaction (RT-PCR) [19]. All specimens that tested negative
by RT-PCR were further tested by anti-DENV IgM antibody
capture ELISA (InBios International, Inc.; Seattle, WA). Unless a
convalescent specimen was available, specimen diagnosis was
based on the single acute specimen.
Figure 1. Epidemic curve of suspected dengue cases by date of illness onset in the Republic of the Marshall Islands, October 2011–
February 2012. Laboratory case definition and date of illness onset were compiled as indicated. Only one date per week is shown on the x-axis.
doi:10.1371/journal.pone.0108445.g001
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Definitions
A suspected dengue case was an individual for whom a health
care provider suspected dengue as the cause of illness and reported
the case to MOH. A laboratory-positive case was a suspected
dengue case for which: 1) DENV nucleic acid was detected by RT-
PCR; 2) DENV non-structural protein 1 (NS1) was detected by
RDT; or 3) anti-DENV IgM antibody was detected by RDT or
ELISA. A laboratory-negative case was a suspected dengue case
that had no laboratory diagnostic evidence of DENV infection.
Dengue, dengue with warning signs, and severe dengue were
defined according to 2009 WHO guidelines [2].
Primary and secondary DENV infections
A representative sample of all laboratory-positive cases was
selected to estimate the rates of primary and secondary infection.
Cases were stratified by age group with optimal allocation for
comparison between age groups. Sample size was calculated to
estimate the proportion of secondary infections by age group based
on data from the 2010 dengue epidemic in Puerto Rico [20], an
error of 20%, 95% significance, and an expected 20% of
specimens having insufficient specimen for testing. Of 218 selected
acute (i.e., collected within five days of illness onset) specimens,
194 (89%) were tested at a dilution of 1:100 to detect anti-DENV
IgG antibody by ELISA using DENV-1–4 antigen and a cut-off
value of OD450$0.15 [21,22]. Secondary infection was defined by
detection of anti-DENV IgG antibody in a laboratory-positive
acute specimen. Primary infection was defined by lack of detection
of anti-DENV IgG antibody in a laboratory-positive acute
specimen.
Sequencing and phylogenetic analysis
Serum specimens in which DENV nucleic acid was detected
and with CT values ,25 were inoculated into cultures of C6/36
cells, in which growth of DENV was detected by RT-PCR and
indirect immunofluorescence [23]. Viral RNA was extracted from
culture supernatant using the Universal BioRobot System (Qiagen;
Valencia, CA). The envelope glycoprotein (E) gene (1,485 base
pairs) was successfully amplified and sequenced in one specimen.
Multiple sequence alignment with 39 other Indonesian genotype
strains obtained from GenBank was performed using ClustalW
available in MEGA 5 (megasoftware.net). GTR+C+I4 was selected
as the best nucleotide substitution model by MODELTEST v3.7.
Phylogenetic relationship was inferred by 60 million Markov
Chain Monte Carlo run in BEAST v1.7.5 (beast.bio.ed.ac.uk)
under Bayesian skyline prior assuming a relaxed lognormal
molecular clock. All ESS values reported .400. A Bayesian
maximum credibility tree was constructed in TreeAnnotator
(found in the same BEAST package) and visualized in FigTree
v1.3.1. Posterior probabilities were used as statistic for internal
nodes. Maximum likelihood phylogenetic trees with 1,000
bootstrap replicates were also inferred using MEGA 5; both trees
rendered nearly identical tree topologies, confirming genetic
relatedness. Genotype was referred to by previously described
nomenclature [24,25].
Entomology
Relative abundance and species composition of juvenile
mosquito populations in aquatic container habitats were assessed
in 155 households on Majuro atoll during 3–8 November, 2011.
Sampling focused on four communities (Rita, Uliga, Long Island
and Laura) where the incidence of suspected dengue was high
during 10 October–5 November 2011. All outdoor container
habitats at selected households were inspected for the presence of
standing water, juvenile mosquitoes, and if .20 pupae were
present in the container. Mosquito specimens were retained from a
subset of samples from each container habitat class and preserved
in ethanol (larvae) or reared to eclosion (pupae) for identification to
species.
Figure 2. Atoll of residence of suspected dengue cases identified in the Republic of the Marshall Islands, October 2011–February
2012. Laboratory case definition and atoll of residence were compiled as indicated. Asterisks indicate atolls with laboratory-positive cases. Ebeye
island is located on Kwajalein atoll.
doi:10.1371/journal.pone.0108445.g002
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Statistical analyses
All surveillance data were entered into a Microsoft Access
(Microsoft Corporation, Redmond, WA) database at MOH. Rates
of suspected and laboratory-positive dengue cases were calculated
using population denominators from the 2011 RMI Census [18].
Unless otherwise stated, statistical differences in proportions were
evaluated using the Chi-squared test. The nonparametric equality-
of-medians test was used to compare median age between groups.
Relative risk ratios (RR) were used to calculate differences between
effect sizes. Graphs were produced in Microsoft Excel (Microsoft
Corp., Redmond, WA). Statistical calculations were performed in
EpiInfo7 (CDC, Atlanta, GA).
Ethics statement
This investigation underwent institutional review at CDC and
was determined to be public health practice and not research; as
such, Institutional Review Board approval was not required. All
specimens tested in RMI were not anonymized to facilitate
reporting of diagnostic test results to clinicians. All specimens sent
to CDC were anonymized prior to shipment.
Figure 3. Age distribution of laboratory-positive dengue cases in the Republic of the Marshall Islands, October 2011–February
2012. A: Age distribution by sex and rate of laboratory-positive cases; B: Primary and secondary DENV infections by age group from a representative
sample of all laboratory-positive cases; error bars indicate standard error.
doi:10.1371/journal.pone.0108445.g003
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Figure 4. Bayesian maximum clade credibility phylogenetic tree of DENV-4 detected during the 2011–2012 dengue outbreak in the
Republic of the Marshall Islands. N = 40 E gene sequences (1,485 basepairs). Internal nodes supported by posterior probability. The dot indicates
the DENV-4 isolated from the Republic of the Marshall Islands in 2011 (GenBank accession number JX891655).
doi:10.1371/journal.pone.0108445.g004
Table 1. Demographic and clinical characteristics of suspected dengue cases reported during an outbreak in the Republic of the






N = 1,603 N = 867 N = 657


























Dengue, n (%) 1,241 (77) 688 (79) 495 (75)
Hospitalized, n (%) 160 (10) 110 (13) 47 (7.2)
Hemorrhage, n (%) 84 (5.2) 40 (4.6) 42 (6.4)
















































Numbers in bold indicate a significant difference in proportions (Chi-squared, p,0.05) between laboratory-positive and -negative cases.
*79 cases were not tested.
{Sex was not reported for 34 cases.
`Ethnicity was not reported for 264 cases.
doi:10.1371/journal.pone.0108445.t001
Dengue Outbreak in the Marshall Islands
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e108445
Results
Case identification
The first identified laboratory-positive case had onset of illness
on October 14, 2011 and resided in Majuro atoll (Fig. 1). The
number of suspected cases began to increase steeply one week later
and peaked on November 4. Cases continued to be identified at
comparatively low levels through the first months of 2012, and the
outbreak was declared over in February. A median of 8 (range: 0–
54) suspected cases were identified per day during the outbreak.
Diagnostic testing
Serum specimens were collected upon presentation from all
patients with dengue-like illness. Specimens were collected a
median of two days (25th–75th quartile: 1–3) post-onset of illness.
Table 2. Abundance and distribution of juvenile mosquitoes in water-filled containers identified during household surveys (N =
155) on Majuro atoll, Republic of the Marshall Islands, 3–8 November, 2011.
Container Class
(representative types) Number of Containers per 100 Households (% of Water-filled Containers Inspected)
With Water Larvae or Pupae Present .20 Pupae Present
Water Storage
(tanks, cisterns, drums)
235 133 (57) 17 (7)
Discarded Tires 76 67 (88) 5 (7)
Domestic Utensils in Use
(buckets, cooking pots,
wash tubs, garbage cans)
105 58 (56) 4 (14)
Containers with Plants
(planter pots, vases)
28 21 (75) 2 (7)
Small Refuse
(bottles, cans, food packaging)
83 55 (67) 1 (1)
Natural Containers
(coconut shells, tree holes, leaf axils)








54 24 (45) 3 (5)
Total 650 413 (64) 34 (5)
doi:10.1371/journal.pone.0108445.t002
Figure 5. Aedes species composition in juvenile mosquito samples collected from water-filled containers on Majuro atoll, Republic
of the Marshall Islands, 3–8 November, 2011. Examples of habitat types in each container class are provided in Table 2.
doi:10.1371/journal.pone.0108445.g005
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Paired acute and convalescent specimens were available for 59
(3.7%) cases.
Of 1,603 suspected dengue cases identified during the outbreak
(3.0% of RMI residents), 657 (41%) were laboratory-negative, 79
(4.9%) were not tested, and 867 (54%; 1.6% of RMI residents)
were laboratory-positive. Of 1,379 specimens tested with the RDT
in RMI, 626 (45%) were positive: 536 (86%) by detection of NS1,
73 (12%) by detection of anti-DENV IgM antibody, and 17 (2.7%)
by detection of both NS1 and anti-DENV IgM antibody. From a
convenience sample of 845 RDT-positive and -negative specimens
sent to CDC and tested by RT-PCR, DENV-4 was detected in
482 (57%) and was the only DENV detected during the outbreak.
Of the 363 specimens that tested negative by RT-PCR and were
further tested by IgM ELISA at CDC, anti-DENV IgM antibody
was detected in 45 (12%).
Epidemiologic findings
Laboratory-positive cases were identified from seven of the 25
inhabited atolls and islands that comprise RMI (Fig. 2). Among
these regions, the median rate of suspected and laboratory-positive
cases per population was 2.4% (range: 0.1–4.6%) and 0.6% (range:
0.2–2.7%), respectively; both were highest in Majuro atoll.
Most (72%) laboratory-positive cases were aged 10–29 years
(Fig. 3A). The highest rate of laboratory-positive cases per
population (3.4%) was in individuals aged 15–19 years, and lowest
(0.4%) in individuals aged 0–4 or $70 years. Males and females
were equally represented in all age groups except 0–4 year-olds
(p,0.001), in which 79% of laboratory-positive cases were male.
Primary and secondary DENV infections
From a representative sample of 194 laboratory-positive acute
specimens, 184 (95%) had evidence of secondary infection
(Fig. 3B). Rate of secondary infection by age group was 50% in
0–4 year-olds, and increased with age group until a plateau of
,90% was reached in 10–14 year-olds.
Molecular epidemiology
Following virus isolation and E gene sequencing, Bayesian
phylogenetic analysis demonstrated that the virus circulating in
RMI is distinct from other DENV-4 previously identified in the
Pacific islands, and instead belongs to clade II of the Indonesian
genotype that is geographically associated with Southeast Asia
(Fig. 4). The most closely related DENV-4 was isolated from cases
that occurred in 2012: an individual from Japan with travel history
to RMI, and a resident of Chuuk, FSM. Other closely related
viruses were detected in Singapore in 2011 and Indonesia in 2004.
Disease severity
Laboratory-positive cases were not significantly associated with
sex, age, or ethnicity (Table 1). Although more laboratory-positive
(79%) than laboratory-negative (75%) cases met the 2009 WHO
dengue case definition [2], this difference only approached
statistical significance (p = 0.06). Laboratory-positive case-patients
were 1.8 (95% confidence interval [95% CI]: 1.3–2.5) times more
likely to be hospitalized than laboratory-negative case-patients (p,
0.001). Laboratory-positive case-patients had dengue with warning
signs significantly more frequently than laboratory-negative case-
patients (p = 0.02). The most frequently identified warning signs
among laboratory-positive case-patients were persistent vomiting
(35%) and abdominal pain (59%); the latter was significantly more
common in laboratory-negative cases (75%; p = 0.007). Fluid
accumulation (e.g., pleural effusions, ascites) was only observed in
laboratory-positive cases (Fischer’s exact test, p = 0.16). Concom-
itant rise in hematocrit and decrease in platelets was 4.3 times
(95% CI: 2.2–8.4) more likely to occur in laboratory-positive than
laboratory-negative case-patients (p,0.001). Six (0.7%) laborato-
ry-positive case-patients had severe dengue. No fatal cases were
reported.
Maternal and infant cases
Four infants aged ,1 year tested positive with the RDT: three
by detection of NS1, and one by detection of anti-DENV IgM
antibody; all were hospitalized. One infant was a neonate male
born to a febrile mother in whom NS1 was detected on the day of
parturition. On day seven of life, the infant developed severe
dengue with cyanosis and severe bleeding requiring blood
transfusion. Both the baby and mother recovered and were
ultimately discharged. As 111 pregnant women gave birth during
the outbreak, the rate of documented vertical DENV transmission
resulting in dengue during the outbreak was 0.9% (1/111). Four
additional pregnant, laboratory-positive females were identified
during the outbreak; all recovered without complication. No
reported fetal losses or perinatal deaths were associated with
maternal DENV infection during the outbreak.
Atypical clinical cases
An 11-year-old boy from Utrik atoll had onset of fever in early
November and subsequently had streaks of blood in his stool. After
being transported to Majuro Hospital, he was given intravenous
ampicillin, cephazoline, and metronidazole for a presumptive
diagnosis of typhoid fever; however, his fever persisted. White
blood cell count, platelet count, hemoglobin, and hematocrit were
normal. NS1 was detected on day 8 of illness, and Salmonella
typhi was identified in a blood culture the following day. He was
discharged home in stable condition after seven days of
hospitalization.
An 18-year-old male in his third month of treatment for leprosy
was admitted with a two-day history of fever and malaise. On
examination he was febrile with patchy nodular skin lesions on the
trunk and extremities. NS1 and DENV-4 were detected in a serum
specimen. His hospital course was unremarkable and he continued
treatment for leprosy, including a decreased dose of prednisone.
He was discharged on day six of hospitalization.
Entomologic findings
Mosquito larvae or pupae were detected at 87% of inspected
homes (i.e., House Index) and in 64% of containers with standing
water outside homes (i.e., Container Index), with an estimated
density of 413 mosquito-positive containers per 100 households
(i.e., Breteau Index) (Table 2). Indoor inspections were performed
at a subset of selected households; however, water-filled containers
were rarely observed and all were negative for juvenile Aedes spp.
mosquitoes (data not shown). Large water storage receptacles were
the most abundant water-filled container (235 per 100 households
inspected), and accounted for 32% of mosquito-positive containers
and 50% of containers with .20 pupae. Discarded tires, domestic
utensils (e.g., washing or cooking items, trash containers) and small
refuse items (e.g., cans, disposable food packaging) collectively
represented 44% of mosquito-positive containers and 29% of
containers with .20 pupae.
A total of 738 Aedes spp. juveniles collected from 109 containers
with larvae or pupae were identified to species (Fig. 5). Specimens
of Ae. aegypti were identified in all juvenile mosquito samples
collected from water storage containers, either alone or co-
occurring with Ae. albopictus. Ae. albopictus was the most
frequently identified species in samples collected from all other
container classes except large refuse items. Specimens of Ae.
Dengue Outbreak in the Marshall Islands
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marshallensis were rarely collected from artificial container
habitats, but were present in almost half of samples from natural
container habitats concurrently with Ae. albopictus. Culex spp.
larvae and pupae specimens were present in 13 samples, with the
greatest frequency in discarded tires (6 [27%] of 22 samples).
Discussion
The epidemiologic characteristics of this outbreak were
captured by improving public and clinical awareness of dengue,
enhancing surveillance to enable rapid case reporting, and use of a
RDT followed by confirmatory testing to define dengue cases.
Pertinent findings include 3% of all RMI residents being reported
as a suspected dengue case, laboratory confirmation of dengue in
3% of Majuro residents, hospitalization of 13% of dengue cases,
and identification of water storage containers as prominent sources
of vector mosquitoes. The prevalence of secondary infection in all
age groups demonstrates that DENVs regularly circulate in RMI.
The rate of suspected dengue cases observed during this
outbreak (3%) was similar to that recently reported from FSM and
the Solomon Islands [8,11], but was not as high as the 10–50%
reported during ‘‘virgin soil’’ outbreaks in Tonga in 1975 [26] and
Niue in 1985 [27]. Moreover, the rate of severe dengue (0.6%) was
not particularly high, and no fatal cases were detected. Rates of
DHF and fatal dengue in prior outbreaks in the Pacific ranged
from 2–8% [5,9] and 0.4–1.2% [5,26], respectively. Possible
explanations for apparent differences in both the attack rate and
rate of severe case detection include dissimilarities in: prior DENV
transmission, which presumably had not occurred in Tonga and
Niue but did in RMI, and consequent differences in immunologic
susceptibility of the population; sequence of and time between
patients’ DENV infections, which can affect disease severity [2,28–
30]; and most dengue patients having access to medical care at
Majuro Hospital and seeking care early, which likely improved
identification of dengue cases from across the clinical spectrum
and may have reduced the number of severe dengue cases,
respectively. Last, establishing dengue wards in Majuro Hospital
and training clinicians in the current best practices in dengue
patient management may have prevented fatal cases, as has been
previously reported [31].
Several studies have demonstrated that primary infection with
DENV-4 infrequently causes clinically apparent illness [20,32–37].
Consistent with these observations, the overwhelming majority of
cases in this investigation were experiencing secondary infection
with DENV-4. During a community survey conducted during a
DENV-4 outbreak in FSM in 1995, 6% of residents experienced a
dengue-like illness, anti-DENV IgM seroprevalence was 6–36%,
and nearly all residents had been previously infected with a DENV
[10]. Although anti-DENV seroprevalence was not determined
during the RMI outbreak, the findings from FSM and elsewhere
suggest that many primary infections may have occurred in
individuals in RMI who did not develop clinically apparent illness,
suggesting a higher rate of DENV infection than was documented.
Moreover, the high rate of clinically apparent dengue cases in
individuals aged 10–29 years, nearly all of which were secondary
infections, compared to the rate in individuals aged ,10 years
suggest a dengue outbreak occurred in RMI 10–15 years ago. This
is in agreement with anecdotal reports from clinicians at Majuro
Hospital of an outbreak of dengue-like illness in the early 2000s
(MOH, unpublished data). Finally, the observation that .70% of
dengue case-patients aged 0–9 years were experiencing secondary
infection demonstrates that DENVs regularly circulate in RMI.
Therefore, dengue cases occurring before the 2011–2012 outbreak
may have been overlooked due to a lack of surveillance for and/or
clinical awareness of dengue.
Interestingly, the DENV-4 that caused the RMI outbreak was
distinct from other DENV-4 circulating previously in the Pacific,
but was nearly identical to viruses isolated from dengue patients in
2012 from FSM and another with travel history to RMI.
Moreover, the genetic relatedness of the DENV-4 from RMI to
DENV-4 from Southeast Asia suggests that human travel from
Southeast Asia resulted in the RMI outbreak, which subsequently
spread to FSM. A similar chain of events enabled spread of
DENV-4 throughout Pacific islands in 2009 [7].
Although Ae. aegypti was likely the primary mosquito vector
responsible for DENV transmission during the RMI outbreak, Ae.
albopictus is also a competent vector and may have contributed to
DENV transmission, as was recently suggested to be the case in
FSM [38]. First detected in RMI from a single container habitat
on Majuro Atoll in 1981 [39], Ae. albopictus has since been
collected from multiple locations within RMI (Harry M. Savage,
personal communication). Our results confirm that this species is
now well established on Majuro atoll, representing the vector
species most frequently recovered from domestic container
habitats other than large water storage and refuse items. Ae.
marshallensis may also have contributed to DENV transmission,
although the vector competence of this species is unclear [40,41].
The high abundance of water storage containers infested with
Ae. aegypti suggests they were the most important source of vector
mosquitoes. Since only 5% of households in RMI have access to
piped water, 79% of households store rainwater and the
remainder rely on well or bottled water [18]. Conventional (e.g.,
cisterns) and ad-hoc (e.g., re-purposed chest freezers) water storage
containers frequently lacked screens or tight-fitting covers to
preclude mosquito access. In contrast, 1,500 gallon water
catchment systems had been recently installed in some households
[18] and had tight-fitting lids or mesh screens sealing all entry
points; no mosquito juveniles were detected in such containers.
These findings emphasize the importance of designing and
managing water storage containers that are inaccessible to
mosquitoes, and highlight the benefits of cooperative programs
for improving water collection and storage. Such improvements
should be paired with householder education to ensure sustain-
ability [42]. The high colonization rate of discarded tires by vector
mosquitoes, particularly Ae. albopictus, was similar to observations
from a recent dengue outbreak in FSM [8]. Sustainable dengue
prevention strategies should incorporate long-term solutions to
manage solid waste and outreach to householders on the
importance of preventing mosquito development around their
home.
This investigation was subject to several limitations. Because
confirmatory diagnostic testing was not performed for nearly half
of suspected cases that were tested only by RDT, which may yield
false-negative test results [43], the true incidence of dengue was
likely higher than was reported here. Nonetheless, because nearly
half of suspected dengue cases had no evidence of DENV infection
and abdominal pain was more common in laboratory-negative
cases, the etiology of non-dengue causes of acute febrile illness
(e.g., typhoid fever [44], leptospirosis [45], rickettsioses [46], other
arboviruses [47]) should be further investigated in RMI to enable
appropriate patient management. Also, vector surveillance data
were not collected after application of pesticides, and thus we were
unable to evaluate the efficacy of vector control activities in
controlling either juvenile or adult mosquito populations. Finally,
because it is unclear if other flaviviruses have circulated previously
in RMI, some individuals defined as experiencing secondary
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infection may have been misclassified due to antibody cross-
reactivity between flaviviruses [48].
This outbreak demonstrated the acute burden that a dengue
outbreak can have in a Pacific island population. To reduce the
likelihood of future outbreaks, evidence-based behavioral and
interventional approaches to reduce mosquito vector populations
should be developed and routinely implemented. Dengue surveil-
lance should continue to be strengthened in RMI and other Pacific
island countries to rapidly detect and respond to outbreaks. In
anticipation of a dengue vaccine, the age group of individuals
affected by dengue in the Pacific should be elucidated to better
inform vaccine campaigns.
Supporting Information
Figure S1 Map depicting the geographic location of the
Republic of the Marshall Islands. Source: http://www.
travelpod.com/bin/graphics/maps/country/large/mh-map.gif.
Published under the Creative Commons-BY license.
(TIF)
Figure S2 Dengue Surveillance Forms used to capture
demographic, clinical and laboratory data for suspected
dengue cases reported to the Ministry of Health during a
dengue outbreak in the Republic of the Marshall
Islands, October 2011–February 2012. A: Surveillance form
used to capture data at presentation. B: Surveillance form used to
capture data at discharge or during follow-up evaluation.
(TIF)
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